Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
| dc.contributor.author | Loaiza-Giraldo, Jessica Paola | |
| dc.contributor.author | Amigo-Fierro, Florencia | |
| dc.contributor.author | Cancino-Castro, Camila Ignacia | |
| dc.contributor.author | Donoso-Emig, Matias | |
| dc.contributor.author | Satea, Murtaja | |
| dc.contributor.author | Farías-Quinteros, Ignacia | |
| dc.contributor.author | Bruna-Mejias, Alejandro | |
| dc.contributor.author | Nova-Baeza, Pablo | |
| dc.contributor.author | Orellana-Donoso, Mathias | |
| dc.contributor.author | Gutiérrez-Espinoza, Héctor | |
| dc.contributor.author | Cifuentes-Suazo, Gloria | |
| dc.contributor.author | Sanchis-Gimeno, Juan | |
| dc.contributor.author | Piagkou, Maria | |
| dc.contributor.author | Valenti, Vitor E. | |
| dc.contributor.author | Leon-Rojas, Jose E. | |
| dc.contributor.author | Valenzuela-Fuenzalida, Juan José | |
| dc.coverage.spatial | Reino Unido | |
| dc.date.accessioned | 2026-09-16T18:55:38Z | |
| dc.date.available | 2026-09-16T18:55:38Z | |
| dc.date.issued | 2026-06-05 | |
| dc.description.abstract | Objectives: Diabetes mellitus (DM) is a chronic metabolic disorder characterized by insulin resistance, impaired insulin secretion, and increased cardiometabolic and inflammatory burden. Zinc plays a key biological role in insulin synthesis, storage, signalling and antioxidant defence; however, the clinical relevance and consistency of zinc supplementation effects in diabetes remain uncertain. Methods: A systematic search of PubMed/MEDLINE, Web of Science, Scopus, CINAHL and Google Scholar was conducted to identify randomized controlled trials (RCTs) assessing zinc supplementation in individuals with diabetes, gestational diabetes or prediabetes. Results: Eighteen RCTs involving 1023 participants met the eligibility criteria. Zinc supplementation significantly increased plasma zinc concentrations (MD = 7.80; 95% CI 4.33 to 11.26) and improved insulin resistance, as reflected by reductions in serum insulin (MD = -2.50; 95% CI -4.69 to -0.31) and HOMA-IR (MD = -1.10; 95% CI -2.05 to -0.15). Total cholesterol decreased modestly but significantly (MD = -5.70; 95% CI -7.50 to -3.89), representing a relatively small absolute reduction, while LDL cholesterol showed a modest increase (MD = 3.46; 95% CI 1.48 to 5.43), although the clinical relevance of this finding remains uncertain. Inflammatory and oxidative stress markers improved, including reductions in C-reactive protein (SMD = -0.91; 95% CI -1.43 to -0.38) and malondialdehyde (SMD = -0.76; 95% CI -1.34 to -0.18), alongside an increase in total antioxidant capacity (SMD = 1.79; 95% CI 0.68 to 2.91). Conclusions: Zinc supplementation was associated with improvements in insulin resistance, inflammatory status and oxidative stress markers in individuals with diabetes. | |
| dc.identifier.citation | Endocrinology, Diabetes & Metabolism, Vol. 9, N° 5 (2026) pp. 1-22 | |
| dc.identifier.doi | https://doi.org/10.1002/edm2.70264 | |
| dc.identifier.issn | 2398-9238 | |
| dc.identifier.orcid | https://orcid.org/0000-0002-1781-062X | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12254/7741 | |
| dc.language.iso | en | |
| dc.publisher | John Wiley & Sons Ltd. | |
| dc.rights | Atribución-NoComercial-CompartirIgual 3.0 Chile (CC BY-NC-SA 3.0 CL) | |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/cl/ | |
| dc.subject | diabetes mellitus | |
| dc.subject | inflammation | |
| dc.subject | insulin resistance | |
| dc.subject | oxidative stress | |
| dc.subject | randomized controlled trials | |
| dc.subject | type 2 diabetes | |
| dc.subject | zinc supplementation | |
| dc.title | Effects of Zinc Supplementation on Glycemic Control, Insulin Resistance, Inflammation and Oxidative Stress in Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials | |
| dc.type | Article |
Archivos
Bloque original
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- Paper 15 2026.pdf
- Tamaño:
- 3.6 MB
- Formato:
- Adobe Portable Document Format
Bloque de licencias
1 - 1 de 1
No hay miniatura disponible
- Nombre:
- license.txt
- Tamaño:
- 347 B
- Formato:
- Item-specific license agreed upon to submission
- Descripción: